Back to School for Biotech
How Academia and Industry Can Collaborate to Advance Biologic Drug Development and Manufacturing
The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Addressed Concerns Around Clinics Offering Cellular Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
Reprints And Permissions
Genetic Engineering & Biotechnology News (GEN) is pleased to announce our partnership with Copyright Clearance Center to meet your licensing needs.
With Copyright Clearance Center's Rightslink® service it's faster and easier than ever before to secure permission from GEN to reuse our content in a book, journal/magazine, newsletter/newspaper, CD-ROM/DVD, brochure/pamphlet, photocopy, coursepack, email, slide kit/presentation or order reprints.
Simply locate your desired content on http://www.genengnews.com/, click the Reprints link in the Keywords and Tools section to open Rightslink.
- Select the way you would like to reuse the content
- Create an account if you haven't already
- Accept the terms and conditions and you're done
For questions about using the Rightslink service, please contact Customer Support via phone 877/622-5543 (toll free) or 978/777-9929, or email [email protected]
If you prefer, please contact us directly:
Reprints & Permissions
Mary Ann Liebert, Inc., publishers
(914) 740-2100 or (800) M-LIEBERT